Prevalence of Pharyngolaryngeal Reflux in Patients Treated for Obstructive Sleep Apnea Syndrome (RESTECH)

Elsan

Status

Completed

Conditions

Reflux, Laryngopharyngeal

Obstructive Sleep Apnea

Treatments

Diagnostic Test: Polysomnography

Diagnostic Test: Pharyngeal ph-metry Restech

Procedure: Peptest

Behavioral: Questionnaire RSS-12

Procedure: Reflux Sign Assessment

Study type

Interventional

Funder types

Other

Identifiers

NCT05110352

2020-A02789-30

Details and patient eligibility

About

The aim of the study is to find, using validated and efficient tools, a laryngopharyngeal reflux in patients receiving polysomnography for suspected obstructive sleep apnea syndrome.

It is proposed to carry out simultaneously, at the Sleep Center of the Polyclinique of Poitiers (CSPP), a polysomnography, a 24-hour Restech pharyngeal pH-metry (day and night), a Peptest (in the evening and in the morning of the polysomnography), with the RSS-12 questionnaire and the RSA score.

Enrollment

37 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Adults (> 18 ans)
Polysomnography planned for OSA assessment
RPL known or not, suspected or not
Affiliation to a social security scheme or beneficiary of such a scheme
Patient having signed the free and informed consent

Exclusion criteria

Minors
Smoking, alcoholism, chronic or serious disabling pathology
Medical history of upper aerodigestive tract cancer, radiotherapy
Recent infection of upper aerodigestive tract, chronic rhinosinusitis
Permanent nasal obstruction
Active allergy
Non-obstructive SAS (central)
Patient under anti-secretory treatment (IPP) during the 8 days preceding the Restech associated with the PSG
Refusal to participate in the study
Protected patients: Adults under guardianship, guardianship or other legal protection, deprived of liberty by judicial or administrative decision
Pregnant, breastfeeding or parturient
Hospitalized without consent